Blue Owl Capital Holdings »

Cid Holdco shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Cid Holdco (DAICW) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Cid Holdco

Tip: Access up to 7 years of quarterly data

All positions including Cid Holdco held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cid Holdco by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2025-09-30 $46k 300k 0.15
2025-06-30 $20k 300k 0.07

More positions owned by Blue Owl Capital Holdings

Nuveen Churchill Direct Lend Com Shs (NCDL)
Owl Rock Capital Corporation (OBDC)
Engene Holdings (ENGN)
Larimar Therapeutics (LRMR)
Evercommerce (EVCM)
Holley (HLLY)
Roivant Sciences SHS (ROIV)
Cullinan Oncology (CGEM)
Ultragenyx Pharmaceutical (RARE)
Conduent Incorporate (CNDT)
Sagimet Biosciences Com Ser A (SGMT)
Compass Therapeutics (CMPX)
Dell Technologies CL C (DELL)
Civeo Corp Cda Com New (CVEO)
Context Therapeutics (CNTX)

View all positions for Blue Owl Capital Holdings

Top funds holding Cid Holdco

Calamos Advisors
Aristeia Capital
Saba Capital Management
Clear Street
Warberg Asset Management
OZ Management
Periscope Capital
Polar Securities
Wolverine Asset Management
Blue Owl Capital Holdings
Millennium Management
Shaolin Capital Management
Toronto-Dominion Bank
D. E. Shaw & Co
Highbridge Capital Management

View all funds holding Cid Holdco